[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13926-13927]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06813]
[[Page 13926]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-19AEG; Docket No. CDC-2019-0025]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Verona Integron-Encoded Metallo-
[beta]-Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas
aeruginosa Infections Associated with Invasive Medical Procedures in
Tijuana, Mexico. This project is being developed to identify infections
among individuals in the U.S. who had surgery at Facility 1 in Tijuana,
Mexico in order to prevent the spread of resistance in the U.S.
DATES: CDC must receive written comments on or before June 7, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0025 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION: To request more information on the proposed
project or to obtain a copy of the information collection plan and
instruments, contact Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Verona Integron-Encoded Metallo-[beta]-Lactamase (VIM)-Producing
Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with
Invasive Medical Procedures in Tijuana, Mexico--New--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is investigating an outbreak of highly resistant Pseudomonas
aeruginosa infections associated with bariatric surgery at a hospital
in Tijuana, Mexico. Approximately 750 Americans from 45 states have had
surgery at this facility since August 1, 2018. Among these individuals,
approximately 200 had surgery since January 1, 2019, and are still at
risk for developing infection and/or having infections that are still
being treated in the U.S. healthcare system. CDC recently received the
contact information for these exposed individuals to enable public
health response. To help prevent spread of this resistant organism in
U.S. hospitals, and to ensure that individuals who develop infection
get prompt and appropriate treatment, a public health response was
initiated to contact individuals exposed to Facility 1 in order to
assess whether they developed infections and whether they have been
hospitalized since their surgery in Mexico.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals exposed for Verona Integron- 197 1 20/60 66
Facility 1 since January 1, Encoded Metallo-
2019. [beta]-
Lactamase (VIM)-
Producing
Carbapenem-
Resistant
Pseudomonas
aeruginosa
Infections
Associated with
Invasive
Medical
Procedures in
Tijuana,
Mexico: Survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 66
----------------------------------------------------------------------------------------------------------------
[[Page 13927]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-06813 Filed 4-5-19; 8:45 am]
BILLING CODE 4163-18-P